Zacks Investment Research on MSN
Eli Lilly's next-generation obesity drug secures first phase III win
Shares of Eli Lilly LLY rose nearly 2% on Thursday after the company announced that a late-stage study evaluating its ...
Analysts were hoping for a safety profile similar to what was achieved in Phase II but an abnormal sense of touch, called ...
In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...
StockStory.org on MSN
Eli Lilly (LLY) Stock Is Up, What You Need To Know
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.4% in the morning session after the company announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback